Announced Tue, 29 Sept, 2026 · 22:45 IST

AGM 2026: All 10 resolutions passed; borrowing and investment limits raised

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹31.98

prior close

₹32.81

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-1.7% vs market

Pharmaceuticals peers, median of 172sector-0.9%-1.0% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.3

15m

-0.3

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-0.3-1.7-0.9-1.0

Next day

-3.1-1.5-1.5-1.6-1.4

+0.1-1.5+1.6-2.6+2.7

+3.2-0.2+3.4-1.5+4.7

+4.6-0.5+5.1-1.8+6.4

+6.6-3.2+9.9-3.5+10.1

+7.8-2.2+10.0-4.4+12.2

15d

-6.2-9.5+3.2-9.2+2.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kimia Biosciences 33rd AGM held 28 Sep 2026 via video call. All 10 resolutions passed, including FY26 audited financials adoption, reappointment of Sameer Goel, appointment of 3 new directors, and approval to raise borrowing limits under Section 180(1)(c) and increase investment limits under Sections 185 and 186. About 82.5 percent of outstanding shares were polled; promoter group (35.5 million shares) voted 100 percent in favour. Voting was via NSDL and scrutinised by Maya Sharma.

Likely market impact

All resolutions passed with near-unanimous support; expanded borrowing and investment headroom for the company, no dissent signals.